# EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
> **ANDA204131** · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL RX · Approved 2021-06-04
## Drug
- **FDA Application Number:** ANDA204131
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
- **Generic name:** EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
- **Active ingredients:** EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** CHARTWELL RX
- **Manufacturer:** Lupin Pharmaceuticals, Inc.
- **First approval:** 2021-06-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204131)
---
*MORVS · CC0 1.0*